Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
ALLRthis companyAllarity Therapeutics, Inc.	$0.98	-1.38×	1.58×	48.53×	-0.2×	20.0%	100.0%	-3939.1%	-3509.7%	-114.3%	-112.3%	-95.5%	0.14×	1.2×	-68.14×	2.13×	0.0%	1	-6.62	1	C-
CINGCingulate Inc.	$4.31	-1.05×	9.4×	0×	-1.1×	-99.0%	0.0%	0.0%	0.0%	-894.8%	-176.5%	-73.8%	3.5×	0.11×	-21.57×	1.16×	0.0%	2	-3.41	2	C
CRISCuris, Inc.	$0.75	-1.7×	2.38×	1.38×	-1.83×	-1429.1%	99.5%	-348.4%	-80.3%	-138.8%	-464.7%	-209.4%	0.3×	0.66×	-15.06×	0.49×	0.0%	0	-98.45	1	C-
KAPAKairos Pharma, Ltd.	$0.49	-2.37×	2.06×	0×	-1.63×	209.1%	0.0%	0.0%	0.0%	-85.9%	-87.9%	-26.3%	0×	0.85×	0×	27.07×	0.0%	2	-4.85	2	C+
PCSAProcessa Pharmaceuticals, Inc.	$1.90	-0.28×	0.68×	0×	0.13×	88.7%	0.0%	0.0%	0.0%	-243.2%	-250.8%	-301.9%	0×	0.41×	0×	2.54×	0.0%	1	-92.98	2	B-
Peer median	—	-1.38×	2.22×	0×	-1.36×	-5.2%	0.0%	0.0%	0.0%	-191.0%	-213.7%	-141.6%	0.15×	0.53×	-7.53×	1.85×	0.0%	2	-48.92	2	—